Artem A. Basov

Mr. Artem A. Basov

G. N. Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Moskva, Russia
+1
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 February 2024 in Epidemiology and Vaccinal Prevention
Verified
Journal Article
Open access
PDF file
ABArtem A. Basov
Artem A. Basov
SVSonya O. Vysochanskaya
Sonya O. Vysochanskaya
OTO. V. Tsvirkun
O. V. Tsvirkun
TBT. R. Belova
T. R. Belova
SAS. E. Aduguzelov
S. E. Aduguzelov
KYK. A. Yatskovsky
K. A. Yatskovsky
Relevance. Differences in case definition criteria and diagnostic recommendations of pertussis between different countries, pose challenges in the analysis and effective control of disease. An important component of successful surveillance is laboratory diagnostics, which, if used in a timely and quality manner, can influence the rate of reported cases. In addition, current criteria for epidemiological surveillance do not sufficiently take into account the severity of the disease and the vaccination status of the patient, which makes it difficult to take effective preventive measures. Aims. Assess the epidemiological situation regarding pertussis infection in Russia to propose criteria for epidemiological surveillance. Materials and methods. The data was obtained from official state statistics (form No. 2 «Information on infectious and parasitic diseases», No. 5 «Information on preventive vaccinations», No. 6 «Information on the contingents of children and adults vaccinated against infectious diseases») and analytical tables developed at G.N. Gabrichevsky Research Institute of Epidemiology and Microbiology, including information on each case of pertussis and collected from the Rospotrebnadzor Directorates in the Russian Federation (in 2017–2022). Statistical data processing and plotting were carried out with R version 4.1.2. Results. From 2002 to 2017, the incidence of pertussis in Russia did not exceed the established norms. However, in 2019 there was an increase in incidence. In 2023, the incidence of pertussis reached record levels over the past 22 years – 19.0 per 100 thousand population. Vaccination rates against pertussis have remained high since 2003. The structure of cases shows that the majority of pertussis cases occur among unvaccinated children in the first year of life; deaths from pertussis are recorded annually, mainly among unvaccinated children under 2 years of age. From 2017 to 2019, the incidence among the unvaccinated was significantly higher than among the vaccinated; in 2020-2022, incidence among the unvaccinated decreased, but remained higher than among the vaccinated during the period of COVID-19 restrictive measures. There was no statistically significant difference in the distribution of pertussis severity in the periods before and after the COVID19 pandemic. Outbreaks of infection are mostly without spread, and in 2020-2022 the proportion of such outbreaks has increased. Schools remain the main site of infection, but the proportion of cases in kindergartens has increased. Conclusions. The following criteria for epidemiological well-being are proposed: subject to the achievement of timely vaccination coverage in 95% of people of decreed ages and timely implementation of anti-epidemic measures, there should be no deaths from pertussis, the incidence of pertussis should be sporadic and registered predominantly (more than 50% of cases) in the form of mild forms, the majority of pertussis cases occur among unvaccinated children in the first year of life (no more than 30% of vaccinated cases) and outbreaks without the spread of infection should prevail (more than 50% of cases) over outbreaks with spread.

Verified
Journal Article
Open access
PDF file
OFOlga P. Frolova
Olga P. Frolova
OBOlga V. Butylchenko
Olga V. Butylchenko
PGPatimat G. Gadzhieva
Patimat G. Gadzhieva
MTMargarita Yu. Timofeeva
Margarita Yu. Timofeeva
VBValeriia Basangova
Valeriia Basangova
LSLyudmila Petrovna Severova
Lyudmila Petrovna Severova
To date, tuberculosis (TB) remains the primary cause of mortality in human immunodeficiency virus (HIV) patients in Russia. Since the beginning of 2000, a sharp change in the HIV patients’ structure, to the main known risk factors for HIV infection has taken place in Russia. The transmission of HIV through injectable drug use has begun to decline significantly, giving way to the prevalence of sexual HIV transmission today. These changes may require adjustments to organizational approaches to anti-TB care and the treatment of HIV-positive patients. Our study is aimed at identifying changes in TB-HIV coinfection patients’ structures in 2019 compared to 2000. Based on the results obtained, our goal was to point out the parameters that need to be taken into account when developing approaches to improve the organization of TB control care for people with HIV infection. We have carried out a cross-sectional, retrospective, epidemiological study using government TB registry data from four regions in two federal districts of Russia in 2019. The case histories of 2265 patients from two regions with high HIV prevalence, which are part of the Siberian Federal District of Russia, and 89 patient histories from two regions of low HIV prevalence, which are part of the Central Federal District of Russia, were analyzed. We found that parenteral transmission (69.4%) remains the primary route of HIV transmission among the TB-HIV coinfected. The unemployed of working age without disability account for 80.2% of all coinfected people, while the formerly incarcerated account for 53.7% and the homeless account for 4.1%. Those with primary multidrug-resistant TB (MDR-TB) comprise 56.2% of HIV-TB patients. When comparing the incidence of coinfection with HIV among TB patients, statistically significant differences were obtained. Thus, the chances of coinfection increased by 4.33 times among people with active TB (95% CI: 2.31; 8.12), by 2.97 times among people with MDR-TB (95% CI: 1.66; 5.32), by 5.2 times in people with advanced processes in the lungs, including destruction, (95% CI: 2.78; 9.7), as well as by 10.3 times in the case of death within the first year after the TB diagnosis (95% CI: 2.99; 35.5). The absence of data for the presence of TB during preventive examination was accompanied by a decrease in the chances of detecting coinfection (OR 0.36; 95% CI: 0.2; 0.64). We have identified the probable causes of the high incidence of TB among HIV-infected: HIV-patient social maladaptation usually results in delayed medical care, leading to TB treatment regimen violations. Furthermore, self-administration of drugs triggers MDR-TB within this group. Healthcare providers should clearly explain to patients the critical importance of immediately seeking medical care when initial TB symptoms appear.

10 November 2023 in Epidemiology and Vaccinal Prevention
Verified
Journal Article
Open access
PDF file
ABArtem A. Basov
Artem A. Basov
NMN. M. Maksimova
N. M. Maksimova
SVS. O. Vysochanskaya
S. O. Vysochanskaya
OTO. V. Tsvirkun
O. V. Tsvirkun
KYK. A. Yatskovsky
K. A. Yatskovsky
SAS. E. Aduguzelov
S. E. Aduguzelov
Relevance. Diphtheria is one of the dangerous diseases that threaten human life. Immunization is the only means of creating a favorable epidemiological situation. Ensuring the immunity of the population to this infection prevents the occurrence of the rise and spread of diphtheria among the population. One of the ways to assess the state of specific immunity to diphtheria is annual serological monitoring. Aims. Assessment of the state of antidiphtheria immunity in different age groups of the population of the Russian Federation based on seromonitoring data for 2015–2021. Materials and methods. The data of serological monitoring of diphtheria and the state of vaccination of the population by indicator groups from 85 subjects of the Russian Federation in 2015–2021 were analyzed. In just 7 years, in terms of seromonitoring in Russia, 439,874 people were examined for the presence of antibodies to diphtheria, including 73,559 children in the age group of 3–4 years, 74,424 adolescents aged 15–17 years, and 291,891 adults aged 18 and older. During the same period, 12,154 controlled blood sera from 20 subjects of the Russian Federation were examined. In the age group of 3–4 years – 1834 children, 15–17 years – 1366 teenagers, 18–29 years – 1711 adults, 30–39 years – 1724 adults, 40–49 years – 1918 adults, 50–59 years – 1798 adults, 60 years and older – 1803 adults. The presence of antibodies to diphtheria was determined in the course of passive hemagglutination. The protective titers of antibodies were taken to be dilution of sera with a titer of 1:20 or more, the intensity of anti-diphtheria immunity was assessed as follows: antibody titers in dilution of sera 1:20–1:40 – low titers, 1:80–1:160 – medium and 1:320 or more – high titers of antibodies of JSC «Biomed» im. I. I. Mechnikov. Results and discussion. In Russia, improving the surveillance system for diphtheria continues to be an urgent task of the private epidemiology of this infection. The data obtained during the study allowed us to characterize the population immunity of the population of the Russian Federation, as a whole across the country, as sufficient to prevent the occurrence and spread of diphtheria. The main factor contributing to this was the long-term high coverage of vaccinations against diphtheria of persons in the decreed age groups (more than 95% of those vaccinated from the number of persons to be vaccinated in each age group). When comparing the level of immunization of the population depending on age, it was found that the percentage of vaccinated persons in the age group of people 50 years and older was statistically significantly lower than in the group of people younger than 50 years. The data of serological studies in Russia as a whole showed a high proportion of people with protective titers of antibodies to diphtheria in each age group – 3–4 years – 96.7 ± 0.1%, 15–17 years – 98.3 ± 0.1%, 18–29 years – 96,0 ± 0,4% – 97,5 ± 0,3%, 30–39 – 95,9 ± 0,4% – 97,5 ± 0.3%, 40–49 years old – 95,7 ± 0,4% – 97,7 ± 0,3%. The largest proportion of seronegative individuals is detected among groups aged 50–59 years and 60 years and older. The analysis of the share of seronegative persons in certain subjects of the Russian Federation revealed that the number of territories with a share of seronegative persons of more than 10% in the age groups of 50–59 years and 60 years and older was significantly higher than in other age groups. Conclusion. Thus, when planning companies for «сatch-up» immunization, it is advisable to provide mandatory revaccination of seronegative persons over 50 years of age. Timely revaccination according to the National Vaccination Calendar, tracking the proportion of persons susceptible to diphtheria in all indicator groups, followed by revaccination of seronegative persons in older ages will allow maintaining a high level of population immunity (more than 95%) and ensuring a consistently low incidence of diphtheria in the country for many years.

22 May 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Yury V. ZhernovYury V. Zhernov
Yury V. Zhernov
VPVladislava Olegovna Petrova
Vladislava Olegovna Petrova
MSMark Simanduyev
Mark Simanduyev
DSDenis V. Shcherbakov
Denis V. Shcherbakov
RPRoman Polibin 
Roman Polibin 
NFNarmina Юсиф Feyziyeva
Narmina Юсиф Feyziyeva
Microbicides, which are classified as topical antiseptic agents, are a revolutionary advancement in HIV prevention aimed to prevent the entry of infectious agents into the human body, thus stopping the sexual transmission of HIV and other sexually transmitted diseases. Microbicides represent the promise of a new age in preventive measures against one of the world’s most pressing health challenges. In addition to their direct antiviral effects during HIV transmission, microbicides also influence vaginal mucosal immunity. This article reviews microbicides by presenting different drug classifications and highlighting significant representatives from each group. It also explains their mechanisms of action and presents information about vaginal mucosal immune responses, emphasizing the critical role they play in responding to HIV during sexual transmission. The article discusses the following groups of microbicides: surfactants or membrane disruptors, vaginal milieu protectors, anionic polymers, dendrimers, carbohydrate-binding proteins, HIV replication inhibitors (reverse transcriptase inhibitors), and multi-purpose prevention technologies, which combine protection against HIV, other sexually transmitted diseases, and contraception. For each chemical compound, the article provides a brief overview of relevant preclinical and clinical research, emphasizing their potential as microbicides. The article offers insights into the multifaceted impact of microbicides, which signify a pivotal step forward in the pursuit of effective and accessible pre-exposure prophylaxis (PrEP).

21 February 2023 in Frontiers in Pediatrics
Verified
Journal Article
Open access
ABArtem A. Basov
Artem A. Basov
Yury V. ZhernovYury V. Zhernov
Yury V. Zhernov
MKMaria I. Kashutina
Maria I. Kashutina
NKNatalia N. Kashkovskaya
Natalia N. Kashkovskaya
SKSvetlana Yu. Kombarova
Svetlana Yu. Kombarova
OMOleg V. Mitrokhin
Oleg V. Mitrokhin
Despite more than 50 years of primary immunization against diphtheria, pertussis, and tetanus in Russia, complicated illnesses, including fatal ones, still occur. The goal of this preliminary cross-sectional study is to see how well pregnant women and healthcare workers are protected against diphtheria, pertussis, and tetanus. The required sample size (pregnant women and healthcare professionals, as well as pregnant women of two age categories) for this preliminary cross-sectional study was calculated using a confidence value of 0.95 and a probability of 0.05. The required number of participants in each group calculated sample size must be at least 59 people. In the Moscow region (Solnechnogorsk city, Russia), a cross-sectional study of pregnant patients and healthcare professionals interacting with children regularly as part of their job from numerous medical organizations was conducted in the year 2021 (n = 655). Antibodies to diphtheria, tetanus, and pertussis toxoids and microorganisms were measured using an enzyme-linked immunosorbent assay (ELISA). The STATISTICA and IBM SPSS Statistics 26.0 were used to process the study results statistically. Descriptive statistics methods, the Mann–Whitney U-test, discriminant analysis with the stepwise selection and analysis of ROC-curves were applied. IgG against diphtheria was found in 99.5% of pregnant women, tetanus in 91.5%, and pertussis in only 36.5%. According to the results of the discriminant analysis, the value of IgG to pertussis is linked to the value of IgA to pertussis and the gestational periods. Immunity to diphtheria was discovered in 99.1% of medical personnel, tetanus in 96.9%, and pertussis in 43.9%, no significant variations with age. When comparing the levels of immunity of pregnant women and healthcare professionals, it was shown that healthcare workers have greater levels of immunity against diphtheria and tetanus. The novel contribution of this study is that it will reveal the proportion of those vulnerable to pertussis, diphtheria, and tetanus among health workers and pregnant women in all age groups under the current national immunization program in Russia. Considering the data obtained from the preliminary cross-sectional study, we believe that it is necessary to conduct a full-scale study on a larger sample and, based on that, make certain changes to the national immunization program in Russia.

25 November 2025 in Journal of Medical Virology
Verified
Journal Article
Closed access
ASArmen K. Shakaryan
Armen K. Shakaryan
YMYulia M. Mikhailova
Yulia M. Mikhailova
ACAlina V. Chirova
Alina V. Chirova
ECEvgeniya A. Cherepanova
Evgeniya A. Cherepanova
OBOlga Y. Baikova
Olga Y. Baikova
OIOlga Ivanova
Olga Ivanova